AIM To summarise the literature data on hepatitis C virus (HCV)-infected patients concerning
the prevalence of glucose abnormalities and associated risk. METHODS We conducted a …

Hepatitis C virus (HCV) is a hepatotrophic virus and a major cause of chronic liver disease,
including hepatocellular carcinoma, worldwide. The life cycle of HCV is closely associated …

The association between hepatitis C virus (HCV) infection and type 2 diabetes (T2D) has
been known for over 20 years. Cross-sectional and longitudinal studies have shown a …

Metabolic dysfunction-associated fatty liver disease (MAFLD) and viral hepatitis due to
chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infection are common liver …

Background Direct antiviral agents (DAA) demonstrated high efficacy among HCV-infected
patients in registered trials. Nevertheless, the impact of these therapies on liver stiffness …

Purpose: Age and hepatic fibrosis are the factors that increase the risk of hepatocellular
carcinoma over time. We aimed to explore their impact at the initiation of antiviral therapy on …

Chronic infection with hepatitis C (HCV) is a major risk factor in the development of cirrhosis
and hepatocellular carcinoma. Lipid metabolism plays a major role in the replication and …

Although diabetes mellitus (DM) is known to increase the risk of hepatitis C virus (HCV)-
related hepatocellular carcinoma (HCC), the impact of dynamic glucose status on HCC …

Background/aims Hepatitis C virus (HCV) infection is associated with extrahepatic
manifestations such as metabolic abnormalities. The association between chronic hepatitis …

Liver cirrhosis is a leading cause of death in Hispanics and Hispanics who live in South
Texas have the highest incidence of liver cancer in the United States. We aimed at …